US FDA Still Fighting Problems With Pre-ANDA Meeting Requests
Executive Summary
More meeting requests are being denied because the sponsor's pre-meeting package was incomplete, the agency said.
You may also be interested in...
US FDA Preparing For Potential Bolus Of Complex Generic Applications
Increasing number of product development meetings suggests that many complex generics remain in the development stages.
US FDA Preparing For Potential Bolus Of Complex Generic Applications
Increasing number of product development meetings suggests that many complex generics remain in the development stages.
Complex Generic Approval Delays Getting Congressional Attention
US Energy and Commerce Committee leaders request data on complex generic approvals, guidances, saying additional changes may be needed for faster approvals.